Ionis Pharmaceuticals

From Wikipedia, the free encyclopedia
  (Redirected from Isis Pharmaceuticals)
Jump to: navigation, search
Ionis Pharmaceuticals
Formerly called
Isis Pharmaceuticals
Industry Biotechnology
Headquarters Carlsbad, United States
Products Mipomersen, Alicaforsen
Website www.ionispharma.com

Ionis Pharmaceuticals (NASDAQIONS), known as ISIS Pharmeceuticals until December 2015,[1][2] is a publicly traded pharmaceutical company based in Carlsbad, California, United States. It has a single cholesterol-reducing drug in the market and several compounds in the drug pipeline.

The company was founded in 1989 by Stanley Crooke, a former GlaxoSmithKline head of research, with a view to commercialize antisense therapy.[3]

References[edit]

  1. ^ "Isis Pharmaceuticals Changes Name to Ionis Pharmaceuticals". www.prnewswire.com. PR Newswire/ Ionis Pharma. Retrieved 22 December 2015. 
  2. ^ Fikes, Bradley. "From Isis Pharma to Ionis". The San Diego Union-Tribune. San Diego Union Tribune. Retrieved 22 December 2015. 
  3. ^ Crooke, Stanley T (21 July 2011). "The Isis manifesto". Bioentrepreneur. doi:10.1038/bioe.2011.7. 

External links[edit]